Ceragenix to Present Urinary Catheter Data at European Conference
23 avr. 2008 08h19 HE
|
Ceragenix Pharmaceuticals
DENVER -- Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP) (the "Company"), a biopharmaceutical and medical device company focused on infectious disease and dermatology, today announced that it will be...
Ceragenix Receives $1.5 Million Milestone Payment
07 avr. 2008 08h27 HE
|
Ceragenix Pharmaceuticals
DENVER, Apr 07, 2008 -- Ceragenix Pharmaceuticals, Inc. (OTCBB:GXP) (the "Company"), a biopharmaceutical and medical device company focused on infectious disease and dermatology, today announced that...
Ceragenix Enters into Agreement to License CSA-54 and other Ceragenin Compounds To Biopharmaceutical Company for HIV and STD Applications
25 mars 2008 08h09 HE
|
Ceragenix Pharmaceuticals
DENVER--Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP) (the "Company"), a biopharmaceutical and medical device company focused on infectious disease and dermatology, today announced that it has entered...
Ceragenix Completes Patient Visit Phase of Clinical Trial Study to Compare Efficacy of EpiCeram(R) to Elidel(R)
13 mars 2008 17h47 HE
|
Ceragenix Pharmaceuticals
DENVER--Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP) (the "Company"), a biopharmaceutical and medical device company focused on infectious disease and dermatology, today announced that it had...
Dr. Michael Niederman Joins Ceragenix Scientific Advisory Board
29 janv. 2008 09h10 HE
|
Ceragenix Pharmaceuticals
DENVER, Jan 29, 2008 -- Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology today announced that Michael S. Niederman MD, FACP,...
Ceragenin(TM) Compound Demonstrates Potent Activity Against Multidrug Resistant Bacterial Strains of Pseudomonas
20 déc. 2007 08h14 HE
|
Ceragenix Pharmaceuticals
DENVER--Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology today announced that researchers at the Eugene Appelbaum College of...
Ceragenix and Dr. Reddy's Enter Into Distribution and Supply Agreement for EpiCeram(r)
19 nov. 2007 09h27 HE
|
Ceragenix Pharmaceuticals
DENVER--Ceragenix Pharmaceuticals, Inc. (OTCB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology today announced that it has entered into an exclusive distribution and...
Ceragenix Pharmaceuticals to Present at The Rodman and Renshaw BioFin 9th Annual Healthcare Conference in New York City on November 5th
31 oct. 2007 13h10 HE
|
Ceragenix Pharmaceuticals
DENVER -- Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology, today announced that Steven Porter, its Chairman and Chief Executive...
Results of Pre-Clinical Investigation of Ceragenix's Developmental Antibiotic to Prevent Sepsis Presented at International Scientific Meeting
22 oct. 2007 08h37 HE
|
Ceragenix Pharmaceuticals
DENVER, Oct 22, 2007 -- Ceragenix Pharmaceuticals, Inc. (OTCB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology, today announced that researchers at the Johns Hopkins...
Results of Pre-Clinical Investigations of Ceragenix's Developmental Antibiotic to Be Presented at International Scientific Meeting on Infectious Diseases
18 sept. 2007 08h30 HE
|
Ceragenix Pharmaceuticals
DENVER, Sep 18, 2007 -- Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology, today announced that five poster presentations on the...